Antares Pharma, Inc. 

(Public, AMEX:AIS)   Watch this stock   
Find more results for AIS
Nov 10, 2009
Merriman Curhan Ford Investor Summit - Webcast
Nov 9, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 9, 2009
Q3 2009 Earnings Release
Nov 3, 2009
Oppenheimer & Co. Healthcare Conference - Webcast
Sep 10, 2009
Rodman & Renshaw Annual Global Investment Conference
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -135.62% -224.17%
Operating margin -124.07% -215.46%
EBITD margin - -210.46%
Return on average assets -60.66% -50.63%
Return on average equity -233.82% -102.58%
Employees 24 -

Address

250 Phillips Blvd., Suite 290
Ewing, NJ 08618
United States - Map
+1-609-3593020 (Phone)
+1-610-4580756 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Antares Pharma, Inc. discussed on blogs

Ranking All U.S. Stocks by Weekly Performance - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 21, 2009
Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Antares Pharma, Inc. discussions

  View all discussions »

Description

Antares Pharma, Inc. (Antares) is a product development and pipeline company with drug delivery platforms, including Advanced Transdermal Delivery (ATD) gels, disposable pressure assisted auto injection systems (Vibex), reusable needle-free injection systems (VISION), disposable pen injection systems and oral disintegrating (Easy Tec) tablets. Two of these platforms have generated United States Food and Drug Administration (FDA) approved products. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral disintegrating tablets and reusable needle-free and disposable pressure assisted auto injector and pen injector systems. The Company has operating facilities in the United States and Switzerland. Its United States operation manufactures and markets reusable needle-free injection devices and related disposables, and develops disposable pressure assisted auto injector and pen injector systems.

Officers and directors

Leonard S. Jacob M.D., Ph.D.
Chairman of the Board
Age: 60
Bio & Compensation - Reuters
Paul K. Wotton Ph.D.
President, Chief Executive Officer, Director
Age: 49
Bio & Compensation - Reuters
Robert F. Apple CPA
Chief Financial Officer, Executive Vice President; President of Parenteral Products Division
Age: 42
Bio & Compensation - Reuters
Peter Sadowski Ph.D.
Senior Vice President - Parenteral Products Division
Age: 61
Bio & Compensation - Reuters
Dario Carrara Ph.D.
Senior Vice President, Managing Director — Pharmaceutical Group
Age: 44
Bio & Compensation - Reuters
Kaushik J. Dave Ph. D.
Senior Vice President - Product Development
Bio & Compensation - Reuters
Jacques Gonella Ph.D.
Director
Age: 67
Bio & Compensation - Reuters
Anton G. Gueth
Director
Age: 52
Bio & Compensation - Reuters
Thomas J. Garrity
Director
Age: 60
Bio & Compensation - Reuters
Rajesh C. Shrotriya
Director
Age: 64
Bio & Compensation - Reuters